The American Epilepsy Society (AES) proudly endorses the position statement on Intracranial Neuromodulation for Drug-Resistant Epilepsy in Pediatric Patients, authored by the American Association of Neurological Surgeons (AANS) and the Congress of Neurological Surgeons (CNS). This comprehensive statement highlights the safety, efficacy, and long-term benefits of intracranial neuromodulation—including deep brain stimulation (DBS) and responsive neurostimulation (RNS)—as vital treatment options for children and adolescents with drug-resistant epilepsy (DRE). AES supports the call for broader clinical access to these therapies, recognizing their role in improving seizure control, cognitive outcomes, and quality of life.
The full statement is available at:
https://www.aans.org/advocacy/articles/neurosurgery-issues-position-statement-on-intracranial-neuromodulation-for-drug-resistant-epilepsy-in-pediatric-patients-dec-2024